dc-hdr

GSK plays defense on Avandia

in Uncategorized | no responses

They are reaching out to the Lancet and WSJ.

Related Stories

More in Uncategorized

Comments

Previous post: The demise of Flea, who live-blogged his medical malpractice trial

Next post: Chest pain in the ER

dc-ftr